에이프릴바이오

397030KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

13,500KRWMarket close of 10/21 (Wed)

Up +2.27%+300KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)13,100KRWDown -2.96%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
13,320
High
13,910
Low
13,320
Day range
Day range low 13,320 high 13,910, open 13,320, close 13,500, previous close 13,200
Volume
7×10K shares
926.04 million KRW 0.19× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 12,030 to 73,300 won, 2% up from the low

2% of the way up from the lowest close in 1 year (252 sessions) · -81.6% from the high

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Daily moveusual range+2.27%+2.27%, 0.5× the usual (20-session average ±4.87%)
    That day +2.27% · usual ±4.87% · large-move threshold ±9.7%
  • Trading valueusual range0.2×926.04 million KRW, 0.2× the 20-session average
    0.19× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+2.5B KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.